Tirzepatide 30mg
$85.00
Our Tirzepatide 30mg is a lyophilized research peptide with activity at both GIP and GLP-1 receptors. It is studied in laboratory investigations of incretin signalling, glucose regulation and metabolic pathways. For in-vitro research only; not for human or animal use.
Dual GIP/GLP-1 receptor agonist for metabolic research. Research-grade lyophilized powder for in-vitro laboratory use only.
Tirzepatide is a synthetic 39-amino-acid peptide (MW: 4813.45 g/mol) that acts as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Its dual incretin receptor activity makes it a leading research tool for studying glucose homeostasis, insulin secretion dynamics, appetite regulation, and metabolic signaling pathways.
Specifications
- Quantity: 30mg
- Form: Lyophilized powder
- Purity: ≥98% HPLC verified
- Storage: -20°C protected from light
- Molecular Weight: 4813.45 g/mol
- Length: 39 amino acids
Research Applications
- Dual GIP/GLP-1 incretin receptor signaling studies
- Glucose homeostasis and insulin secretion research
- Appetite regulation and energy balance models
- Metabolic and body composition research
For in-vitro laboratory and scientific research purposes only. Not for human or animal consumption.
